Given that late-stage pancreatic cancer plasticity primarily arises from epigenetic mechanisms, this study proposed that mutant p53 contributes to the acquisition of a lethal phenotype by finely adjusting the chromatin landscape. The gene discussed is TP53; the disease is pancreatic neoplasm.